Point-of-Care Market Research Reports & Industry Analysis
This value added aspect of POC testing will become even more essential as the menu for POC tests expands with the availability of more tests for cancer and cardiovascular diseases. These test results are more complex and need the support of professional guidance.
In the meantime, investments in high technology made during the 1990s will begin to find commercial appeal in the next five years and will spawn a new genre of POC diagnostic tests and devices. These technological advances will interact with a number of enabling healthcare delivery trends to change the face of clinical diagnostics and the economics of healthcare in general.
Industry professionals anticipate that patient self-testing will skyrocket because of rising consumer expectations, technological innovations, and the surge of consumer activism in healthcare. Further pharmacies, retail outlets and the physician office are establishing their position for patient wellness screening. As the cost of POC devices becomes more affordable and healthcare organizations have constructed data management infrastructures, point-of-care testing has also become an attractive operational and economical alternative to traditional laboratory-based testing in a variety of situations, including physician office testing, home care and in-hospital care.
Point-of-Care Industry Research & Market Reports
-
Point of Care Diagnostics Global Market Report 2025
... care diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Veterinary Point Of Care Diagnostics Global Market Report 2025
... point of care diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Hemoglobin A1c (HbA1c) Testing Global Market Opportunities And Strategies To 2034 Including: 1) By Type: Laboratory Based Testing; Point Of Care (PoC) Testing 2) By Product Type: Reagents And Kits; Instruments; Software And Services 3) By Technology: Immunoassays; Chromatography; Enzymatic Assays; Boronate Affinity Chromatography; High Performance Liquid Chromatography 4) By End User: Hospitals And Clinics; Diagnostic Laboratories; Homecare Settings Covering: Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd.; Siemens Healthineers AG; Abbott Laboratories; Bio-Rad Laboratories, Inc.
... (HbA1c) testing market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies. Understand how the market ... Read More
-
Cardiac Biomarkers Market Report by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), Location of Testing (Laboratory Testing, Point of Care Testing), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), and Region 2025-2033
... Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac ... Read More
-
Biosensors – A Global Market Overview
... comprises a bioreceptor that clearly recognizes the analyte, along with a transducer for translating the biologically recognized element into a measurable signal. Biosensors are based on specific technologies, including electrochemical, optical, piezoelectric and thermal, each ... Read More
-
South Africa In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)
... The COVID-19 pandemic turned the spotlight on the IVD market since there was an increasing demand for IVD kits and reagents for the rapid and accurate diagnosis of SARS-CoV-2 virus infection among the global population. ... Read More
-
Point-of-Care/Rapid Diagnostics
... CAGR of 7.5% over the analysis period 2024-2030. Other POC Products, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$3.3 Billion by the end of the ... Read More
-
Ovulation Test
... CAGR of 4.0% over the analysis period 2024-2030. Urine Test, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis ... Read More
-
Home Pregnancy Tests (HPT)
... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Digital Devices, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$597.6 Million by the ... Read More
-
Automated and Rapid Microbiological Tests
... Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. GC/CRT (Clinical) Application, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$1.3 ... Read More
-
Influenza Diagnostics
... CAGR of 5.2% over the analysis period 2024-2030. RIDT Test, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$2.0 Billion by the end of the analysis ... Read More
-
Point of Care (POC) Molecular Diagnostics
... reach US$8.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Infectious Diseases Application, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and ... Read More
-
Urinalysis
... 5.0% over the analysis period 2024-2030. Urinalysis Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth ... Read More
-
Rapid Medical Diagnostic Kits
... 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Over the Counter (OTC) Kits, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$10.7 ... Read More
-
Point of Care Data Management Software
... reach US$2.0 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
Cholesterol Testing
... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the ... Read More
-
Rapid Antigen Detection Tests
... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$88.4 Million While China is Forecast to Grow at 12.4% CAGR The Rapid Antigen Detection Tests market ... Read More
-
POC Lipid Testing
... at a CAGR of 3.2% over the analysis period 2024-2030. Hyperlipidemia Application, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$97.0 Million by the end of ... Read More
-
Cardiac Biomarkers
... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More
-
Cardiac POC Testing Devices
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Cardiac Markers Test, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.6 Billion by ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Veterinary Rapid Testing
... at a CAGR of 8.3% over the analysis period 2024-2030. Rapid Testing Kits, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$1.1 Billion by the end ... Read More
-
Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (TB, HAI, STD), Pregnancy), Purchase Mode (Rx, OTC), Technology (Biochemistry, MDx (RT-PCR, INAAT)), Sample (Blood, Urine), End User (Home Care, Hospitals) - Global Forecast to 2029
... that will fuel POC testing is the favourable government initiatives and funding. Globally, governments consider these technologies essential in improving the accessibility of health care, bringing down costs, and enhancing outcomes for patients. Many governments ... Read More
-
POC HbA1C Testing Global Market Opportunities And Strategies To 2033
... CareCovering: Siemens Healthineers AG; F. Hoffmann-La Roche AG; Bio-Rad Laboratories, Inc.; Menarini Group; Danaher Corporation POC HbA1C Testing Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and ... Read More
-
Global Syphilis Rapid Test Kit Competitive Landscape Professional Research Report 2025
... causes syphilis. This kit typically contains all the necessary components for conducting a simple and quick test, including test cassettes, sample collection swabs or lancets, buffer solutions, and instructions for use. The test works by ... Read More
Research Assistance
